Processa Pharmaceuticals (PCSA) Receivables - Accured (2015)
Processa Pharmaceuticals' (PCSA) quarterly Receivables - Accured came in at $3799.0 in Q2 2015.
Processa Pharmaceuticals (PCSA) Receivables - Accured (2015) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 1 years of Receivables - Accured data on file, last reported at $3799.0 in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.84 Bn | 131.99 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.48 Bn | 78.49 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.15 Bn | 55.01 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.54 Bn | 10.14 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.22 Bn | 26.38 Bn | - | - |
| 10 | Processa Pharmaceuticals | 5.87 Mn | 5.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 3,799.00 |
| Jun 30, 2015 | 3,799.00 |